AIF1 and Alzheimer disease: Despite the observed qualitative differences, the IBA1 marker did not show a significant difference in any of the HF fields between the AD and HC groups, nor when testing the total sum of all positive microglial cells per sample (p = 0.23; Table 5, Figure 4).